Search - tctmd.com

Displaying 101 - 120 of 188

Sort: Relevancy | Date

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

News Conference News VIVA 2018

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

November 08, 2018

Automated Email Reminders May Boost IVC Filter Retrieval, Cut Complications

News Daily News

Automated Email Reminders May Boost IVC Filter Retrieval, Cut Complications

October 23, 2018

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

News Daily News

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

October 09, 2018

Existing and Future Therapies for Chronic Deep Vein Thrombosis

Presentation TCT 2018

Existing and Future Therapies for Chronic Deep Vein Thrombosis

Presenter: Raghu Kolluri, Mahmood K. Razavi, Rahul S. Patel

September 21, 2018

After the ATTRACT Trial: Which Patients With Acute Deep Vein Thrombosis Should Receive Endovascular Therapy?

Presentation TCT 2018

After the ATTRACT Trial: Which Patients With Acute Deep Vein Thrombosis Should Receive Endovascular Therapy?

Presenter: Raghu Kolluri, Mahmood K. Razavi, Teresa L. Carman

September 21, 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

August 26, 2018

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

News Daily News

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

Michael O'Riordan

July 23, 2018

VTE Risk Higher in Surgical Patients Who Get Transfusions

News Daily News

VTE Risk Higher in Surgical Patients Who Get Transfusions

June 13, 2018

Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis

News Conference News ACC 2018

Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis

March 12, 2018

MANAGE Suggests Dabigatran Could Be Useful for Treating Myocardial Injury After Noncardiac Surgery

News Conference News ACC 2018

MANAGE Suggests Dabigatran Could Be Useful for Treating Myocardial Injury After Noncardiac Surgery

March 11, 2018

Varicose Veins Linked to Increased Risk of DVT

News Daily News

Varicose Veins Linked to Increased Risk of DVT

February 28, 2018

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

News Daily News

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Michael O'Riordan

February 21, 2018

News Conference News ISET 2018

‘Bioconvertible’ IVC Filter Does Its Job Then Moves On: SENTRY Trial

February 15, 2018

Strategy Safely Rules Out PE Using Clinical Criteria in Low-Risk Patients

News Daily News

Strategy Safely Rules Out PE Using Clinical Criteria in Low-Risk Patients

Michael O'Riordan

February 14, 2018

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

News Daily News

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

February 09, 2018

TCTMD’s Top 10 Most Popular Stories for December 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

December 28, 2017

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

News Daily News

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

December 08, 2017

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

News Daily News

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

September 19, 2017

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

September 15, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.